Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Positron Emission Tomography01:29

Positron Emission Tomography

6.7K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
6.7K
Imaging Studies II: Positron Emission Tomography and Scintigraphy01:25

Imaging Studies II: Positron Emission Tomography and Scintigraphy

358
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
358
Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

295
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
295

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Digital Cognitive Phenotyping for Differential Diagnosis and Monitoring in Neurological Conditions.

Annals of clinical and translational neurology·2026
Same author

Cerebrospinal fluid tap test in normal pressure hydrocephalus.

Practical neurology·2026
Same author

Cortical synchrony is reduced in Alzheimer's disease and relates to arousal state.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Genetic risk of Alzheimer's disease is associated with loss of brain network segregation in midlife.

Communications biology·2026
Same author

Cognitive assessment methods and outcomes following shunt surgery in idiopathic normal pressure hydrocephalus (iNPH): a systematic review and meta-analysis.

Fluids and barriers of the CNS·2026
Same author

Predicting rates of cognitive and functional decline in Alzheimer's disease and mild cognitive impairment.

Communications medicine·2026

Related Experiment Video

Updated: Dec 7, 2025

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
07:45

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

646

Amyloid PET imaging in clinical practice.

Magdalena A Kolanko1,2, Zarni Win3, Flavia Loreto1

  • 1Department of Brain Sciences, Imperial College London, London, UK.

Practical Neurology
|September 25, 2020
PubMed
Summary

Amyloid positron emission tomography (PET) imaging detects brain amyloid plaques, aiding Alzheimer's disease diagnosis. This review guides appropriate use of amyloid PET scans for improved diagnostic accuracy and treatment decisions.

Keywords:
ALZHEIMER’S DISEASEAMYLOIDATTENTIONBEHAVIOURAL DISORDERCOGNITIONCOGNITIVE NEUROPSYCHOLOGYVISUAL ATTENTION

More Related Videos

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

625
Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.2K

Related Experiment Videos

Last Updated: Dec 7, 2025

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis
07:45

Author Spotlight: Standardizing Mouse In Vivo PET Imaging with Body Conforming Molds and Automated Analysis

Published on: October 25, 2024

646
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
05:17

Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451

Published on: April 18, 2025

625
Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography
09:41

Imaging CD19+ B Cells in an Experimental Autoimmune Encephalomyelitis Mouse Model using Positron Emission Tomography

Published on: January 20, 2023

2.2K

Area of Science:

  • Neurology
  • Nuclear Medicine
  • Radiology

Background:

  • Amyloid positron emission tomography (PET) imaging visualizes in vivo brain Aβ deposition, a key Alzheimer's disease hallmark.
  • Clinical utility of amyloid PET is supported by evidence showing improved diagnostic accuracy, certainty, and therapeutic changes.

Purpose of the Study:

  • To provide a practical guide on the appropriate use of amyloid PET imaging.
  • To discuss the three main indications for amyloid PET based on current research and clinical experience.

Main Methods:

  • Review of available research and clinical experience.
  • Discussion of appropriate use criteria and clinical case illustrations.
  • Emphasis on a multidisciplinary approach for patient selection.

Main Results:

  • Amyloid PET imaging enhances diagnostic accuracy and certainty in Alzheimer's disease.
  • Specific clinical scenarios are identified where amyloid PET is justified.
  • Therapeutic strategies can be altered based on amyloid PET findings.

Conclusions:

  • Amyloid PET imaging is a valuable tool in the diagnosis and management of Alzheimer's disease.
  • Adherence to appropriate use criteria and a multidisciplinary approach are crucial for optimal utilization.
  • Understanding interpretation pitfalls is essential for accurate assessment.